Innoblative is a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue diseases. We are developing advanced energy-based surgical solutions to help improve the way surgeons coagulate and ablate soft tissue to achieve better care for patients. Innoblative has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company’s SIRA® RFA Electrosurgical Device. The SIRA® device is investigational for use in BCS and is not yet available for sale in the United States. The SIRA® device is cleared for intraoperative coagulation and ablation of soft tissue.
View Top Employees from Innoblative Designs, Inc.Website | http://www.innoblative.com |
Revenue | $8 million |
Funding | $4.4 million |
Employees | 10 (5 on RocketReach) |
Founded | 2013 |
Address | 965 W Chicago Ave, Chicago, Illinois 60642, US |
Phone | (833) 920-4660 |
Technologies |
HTML,
Nginx,
Microsoft Outlook
+6 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 14 Million |
Keywords | Innoblative |
Competitors | Synoris Technologies Pvt. Ltd. |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Innoblative Designs, Inc. employee's phone or email?
The Innoblative Designs, Inc. annual revenue was $8 million in 2024.
Alyssa Bailey is the Director Of Product Development of Innoblative Designs, Inc..
5 people are employed at Innoblative Designs, Inc..
Innoblative Designs, Inc. is based in Chicago, Illinois.
The NAICS codes for Innoblative Designs, Inc. are [339, 33].
The SIC codes for Innoblative Designs, Inc. are [384, 38].